News for MVMDF Stock

Mountain Valley MD Provides Year-End Business Update, Advances Commercialization Strategies Mountain Valley MD Provides Business Update, Advances Commercialization Mountain Valley MD Announces Acquisition of Exclusive License for Agrarius, Launch of Performance Guarantee Program Mountain Valley MD Announces Stock Option Grant Mountain Valley MD Provides Business Update, Appoints New CFO Mountain Valley MD Announces Planned Appointment of New CFO Effective January 15, 2024 Mountain Valley MD Announces Appointment of New CFO Mountain Valley MD Provides Business Update Mountain Valley MD Announces Publication of Soluvec™ Trial Data in Therapeutic Delivery Mountain Valley MD Executes Soluvec™ 1% License Agreement, Expands Patent Protection Mountain Valley MD Announces Stock Option Grant Mountain Valley MD Announces Transition of Chief Medical Officer to Advisory Role Mountain Valley MD Provides Notice of Redemption for Class “B” Non-Voting Shares. Common Shares Trading on CSE Unaffected Mountain Valley MD Provides Business Update, Focus On Commercialization Phase Mountain Valley MD Commences Commercial Sales of Agrarius, an Agro Plant Technology Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study For Soluvec™1% Mountain Valley MD Holdings Provides Business Update Mountain Valley MD Holdings Appoints Dr. Elizabeth Norton to Advisory Role to Support Key Quicksome™ Vaccine and Cold Chain Projects Mountain Valley MD Holdings Announces Restricted Share Unit Plan, RSU Grant and Stock Option Grant Mountain Valley MD Holdings Completes Licensing Agreement With Red White and Bloom Brands Inc. Mountain Valley MD Holdings Provides Business Update, Results of Shareholder Meeting Mountain Valley MD Holdings Announces Letter of Intent with Red White and Bloom Brands Inc. Mountain Valley MD Holdings Announces Annual Shareholder Meeting Mountain Valley MD Holdings to Graduate to OTCQX Best Market, Updates Broader Up-Listing Strategy Mountain Valley MD Appoints Chief Medical Officer Mountain Valley MD Announces Appointment of Advisors, Stock Option Grant and Provides Uplisting Update Mountain Valley MD Announces Results From Cold Chain Storage Evaluation of Novel Quicksome™ Technology Mountain Valley MD Provides Update on Key Strategic Initiatives: Patent Award, FDA Collaborative Research Agreement, Cold Chain, Dose Sparing, Husbandry, Oncology, TB, Cannabis Mountain Valley MD Receives Successful Results From BSL-4 COVID-19 Clearance Trial on Three Variants Tested With Ivectosol™ Mountain Valley MD Proceeding With Pre-Clinical Cancer Trials, Files Related Cancer Patent Mountain Valley MD Holdings to Commence Trading on OTCQB Market Under Ticker MVMDF